Exact Mass: 757.562125

PC(16:0/18:2(9Z,12Z))

C42H80NO8P (757.562125)

PC(16:0/18:2(9Z,12Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(16:0/18:2(9Z,12Z)), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of linoleic acid at the C-2 position. The palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats, while the linoleic acid moiety is derived from seed oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Palmitoyl-linoleoyl phosphatidylcholine, also known as phosphatidylcholine(16:0/18:2) or pc(16:0/18:2), is a member of the class of compounds known as phosphatidylcholines. Phosphatidylcholines are glycerophosphocholines in which the two free -OH are attached to one fatty acid each through an ester linkage. Thus, palmitoyl-linoleoyl phosphatidylcholine is considered to be a glycerophosphocholine lipid molecule. Palmitoyl-linoleoyl phosphatidylcholine is practically insoluble (in water) and a moderately acidic compound (based on its pKa). Palmitoyl-linoleoyl phosphatidylcholine can be found in a number of food items such as wax gourd, rowanberry, arrowroot, and chicory leaves, which makes palmitoyl-linoleoyl phosphatidylcholine a potential biomarker for the consumption of these food products. Palmitoyl-linoleoyl phosphatidylcholine can be found primarily in blood, saliva, and urine, as well as throughout all human tissues. In humans, palmitoyl-linoleoyl phosphatidylcholine is involved in a couple of metabolic pathways, which include phosphatidylcholine biosynthesis PC(16:0/18:2(9Z,12Z)) and phosphatidylethanolamine biosynthesis PE(16:0/18:2(9Z,12Z)). Moreover, palmitoyl-linoleoyl phosphatidylcholine is found to be associated with schizophrenia. 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine is a phosphatidylcholine 34:2 in which the 1- and 2-acyl groups are specified as hexadecanoyl (palmitoyl) and 9Z,12Z-octadecadienoyl (linoleoyl) respectively. It is a phosphatidylcholine 34:2 and a 1-acyl-2-linoleoyl-sn-glycero-3-phosphocholine betaine. A complex mixture of phospholipids, glycolipids, triglycerides, phosphatidylcholines, phosphatidylethanolamines, and phosphatidylinositols. 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine is a natural product found in Lycoris radiata, Vitis vinifera, and Drosophila melanogaster with data available. Lecithin is a phospholipid with a polar choline found in phosphoester linkage to diacylglycerol. A phosphatidylcholine 34:2 in which the 1- and 2-acyl groups are specified as hexadecanoyl (palmitoyl) and 9Z,12Z-octadecadienoyl (linoleoyl) respectively. Lecithin is regarded as a safe, conventional phospholipid source. Phospholipids are reported to alter the fatty acid composition and microstructure of the membranes in animal cells. Lecithin is regarded as a safe, conventional phospholipid source. Phospholipids are reported to alter the fatty acid composition and microstructure of the membranes in animal cells.

PC(14:0/20:2(11Z,14Z))

C42H80NO8P (757.562125)

PC(14:0/20:2(11Z,14Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(14:0/20:2(11Z,14Z)), in particular, consists of one chain of myristic acid at the C-1 position and one chain of eicosadienoic acid at the C-2 position. The myristic acid moiety is derived from nutmeg and butter, while the eicosadienoic acid moiety is derived from fish oils and liver. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(14:0/20:2(11Z,14Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(14:0/20:2(11Z,14Z)), in particular, consists of one chain of myristic acid at the C-1 position and one chain of eicosadienoic acid at the C-2 position. The myristic acid moiety is derived from nutmeg and butter, while the eicosadienoic acid moiety is derived from fish oils and liver. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PC(14:1(9Z)/20:1(11Z))

C42H80NO8P (757.562125)

PC(14:1(9Z)/20:1(11Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(14:1(9Z)/20:1(11Z)), in particular, consists of one chain of myristoleic acid at the C-1 position and one chain of eicosenoic acid at the C-2 position. The myristoleic acid moiety is derived from milk fats, while the eicosenoic acid moiety is derived from vegetable oils and cod oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(14:1(9Z)/20:1(11Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(14:1(9Z)/20:1(11Z)), in particular, consists of one chain of myristoleic acid at the C-1 position and one chain of eicosenoic acid at the C-2 position. The myristoleic acid moiety is derived from milk fats, while the eicosenoic acid moiety is derived from vegetable oils and cod oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PC(16:1(9Z)/18:1(11Z))

C42H80NO8P (757.562125)

PC(16:1(9Z)/18:1(11Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(16:1(9Z)/18:1(11Z)), in particular, consists of one chain of palmitoleic acid at the C-1 position and one chain of vaccenic acid at the C-2 position. The palmitoleic acid moiety is derived from animal fats and vegetable oils, while the vaccenic acid moiety is derived from butter fat and animal fat. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(16:1(9Z)/18:1(11Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(16:1(9Z)/18:1(11Z)), in particular, consists of one chain of palmitoleic acid at the C-1 position and one chain of vaccenic acid at the C-2 position. The palmitoleic acid moiety is derived from animal fats and vegetable oils, while the vaccenic acid moiety is derived from butter fat and animal fat. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PC(16:1(9Z)/18:1(9Z))

C42H80NO8P (757.562125)

PC(16:1(9Z)/18:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(16:1(9Z)/18:1(9Z)), in particular, consists of one chain of palmitoleic acid at the C-1 position and one chain of oleic acid at the C-2 position. The palmitoleic acid moiety is derived from animal fats and vegetable oils, while the oleic acid moiety is derived from vegetable oils, especially olive and canola oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(16:1(9Z)/18:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(16:1(9Z)/18:1(9Z)), in particular, consists of one chain of palmitoleic acid at the C-1 position and one chain of oleic acid at the C-2 position. The palmitoleic acid moiety is derived from animal fats and vegetable oils, while the oleic acid moiety is derived from vegetable oils, especially olive and canola oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PC(18:1(11Z)/16:1(9Z))

C42H80NO8P (757.562125)

PC(18:1(11Z)/16:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:1(11Z)/16:1(9Z)), in particular, consists of one chain of vaccenic acid at the C-1 position and one chain of palmitoleic acid at the C-2 position. The vaccenic acid moiety is derived from butter fat and animal fat, while the palmitoleic acid moiety is derived from animal fats and vegetable oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(18:1(11Z)/16:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:1(11Z)/16:1(9Z)), in particular, consists of one chain of vaccenic acid at the C-1 position and one chain of palmitoleic acid at the C-2 position. The vaccenic acid moiety is derived from butter fat and animal fat, while the palmitoleic acid moiety is derived from animal fats and vegetable oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PC(18:1(9Z)/16:1(9Z))

C42H80NO8P (757.562125)

PC(18:1(9Z)/16:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:1(9Z)/16:1(9Z)), in particular, consists of one chain of oleic acid at the C-1 position and one chain of palmitoleic acid at the C-2 position. The oleic acid moiety is derived from vegetable oils, especially olive and canola oil, while the palmitoleic acid moiety is derived from animal fats and vegetable oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

PC(18:2(9Z,12Z)/16:0)

C42H80NO8P (757.562125)

PC(18:2(9Z,12Z)/16:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:2(9Z,12Z)/16:0), in particular, consists of one chain of linoleic acid at the C-1 position and one chain of palmitic acid at the C-2 position. The linoleic acid moiety is derived from seed oils, while the palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

PC(20:1(11Z)/14:1(9Z))

C42H80NO8P (757.562125)

PC(20:1(11Z)/14:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(20:1(11Z)/14:1(9Z)), in particular, consists of one chain of eicosenoic acid at the C-1 position and one chain of myristoleic acid at the C-2 position. The eicosenoic acid moiety is derived from vegetable oils and cod oils, while the myristoleic acid moiety is derived from milk fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

PC(20:2(11Z,14Z)/14:0)

C42H80NO8P (757.562125)

PC(20:2(11Z,14Z)/14:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(20:2(11Z,14Z)/14:0), in particular, consists of one chain of eicosadienoic acid at the C-1 position and one chain of myristic acid at the C-2 position. The eicosadienoic acid moiety is derived from fish oils and liver, while the myristic acid moiety is derived from nutmeg and butter. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

PE(15:0/22:2(13Z,16Z))

C42H80NO8P (757.562125)

PE(15:0/22:2(13Z,16Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(15:0/22:2(13Z,16Z)), in particular, consists of one chain of pentadecanoic acid at the C-1 position and one chain of docosadienoic acid at the C-2 position. The pentadecanoic acid moiety is derived from dairy products and milk fat, while the docosadienoic acid moiety is derived from animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.

PE(20:0/P-18:1(11Z))

C43H84NO7P (757.5985083999999)

PE(20:0/P-18:1(11Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(20:0/P-18:1(11Z)), in particular, consists of one chain of arachidic acid at the C-1 position and one chain of plasmalogen 18:1n7 at the C-2 position. The arachidic acid moiety is derived from peanut oil, while the plasmalogen 18:1n7 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PE(20:0/P-18:1(11Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(20:0/P-18:1(11Z)), in particular, consists of one chain of arachidic acid at the C-1 position and one chain of plasmalogen 18:1n7 at the C-2 position. The arachidic acid moiety is derived from peanut oil, while the plasmalogen 18:1n7 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PE(20:0/P-18:1(9Z))

C43H84NO7P (757.5985083999999)

PE(20:0/P-18:1(9Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(20:0/P-18:1(9Z)), in particular, consists of one chain of arachidic acid at the C-1 position and one chain of plasmalogen 18:1n9 at the C-2 position. The arachidic acid moiety is derived from peanut oil, while the plasmalogen 18:1n9 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.

PE(20:1(11Z)/P-18:0)

C43H84NO7P (757.5985083999999)

PE(20:1(11Z)/P-18:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(20:1(11Z)/P-18:0), in particular, consists of one chain of eicosenoic acid at the C-1 position and one chain of plasmalogen 18:0 at the C-2 position. The eicosenoic acid moiety is derived from vegetable oils and cod oils, while the plasmalogen 18:0 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PE(20:1(11Z)/P-18:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(20:1(11Z)/P-18:0), in particular, consists of one chain of eicosenoic acid at the C-1 position and one chain of plasmalogen 18:0 at the C-2 position. The eicosenoic acid moiety is derived from vegetable oils and cod oils, while the plasmalogen 18:0 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PE(22:1(13Z)/P-16:0)

C43H84NO7P (757.5985083999999)

PE(22:1(13Z)/P-16:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(22:1(13Z)/P-16:0), in particular, consists of one chain of erucic acid at the C-1 position and one chain of plasmalogen 16:0 at the C-2 position. The erucic acid moiety is derived from seed oils and avocados, while the plasmalogen 16:0 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.

PE(22:2(13Z,16Z)/15:0)

C42H80NO8P (757.562125)

PE(22:2(13Z,16Z)/15:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(22:2(13Z,16Z)/15:0), in particular, consists of one chain of docosadienoic acid at the C-1 position and one chain of pentadecanoic acid at the C-2 position. The docosadienoic acid moiety is derived from animal fats, while the pentadecanoic acid moiety is derived from dairy products and milk fat. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.

PE-NMe(18:1(9Z)/18:1(9Z))

C42H80NO8P (757.562125)

PE-NMe(18:1(9Z)/18:1(9Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(18:1(9Z)/18:1(9Z)), in particular, consists of two 9Z-octadecenoyl chain at positions C-1 and C2. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. PE-NMe(18:1(9Z)/18:1(9Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. (Lipid Library, Lipid MAPS) [HMDB]

PE(P-16:0/22:1(13Z))

C43H84NO7P (757.5985083999999)

PE(P-16:0/22:1(13Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(P-16:0/22:1(13Z)), in particular, consists of one chain of plasmalogen 16:0 at the C-1 position and one chain of erucic acid at the C-2 position. The plasmalogen 16:0 moiety is derived from animal fats, liver and kidney, while the erucic acid moiety is derived from seed oils and avocados. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PE(P-16:0/22:1(13Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(P-16:0/22:1(13Z)), in particular, consists of one chain of plasmalogen 16:0 at the C-1 position and one chain of erucic acid at the C-2 position. The plasmalogen 16:0 moiety is derived from animal fats, liver and kidney, while the erucic acid moiety is derived from seed oils and avocados. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PE(P-18:0/20:1(11Z))

C43H84NO7P (757.5985083999999)

PE(P-18:0/20:1(11Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(P-18:0/20:1(11Z)), in particular, consists of one chain of plasmalogen 18:0 at the C-1 position and one chain of eicosenoic acid at the C-2 position. The plasmalogen 18:0 moiety is derived from animal fats, liver and kidney, while the eicosenoic acid moiety is derived from vegetable oils and cod oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PE(P-18:0/20:1(11Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(P-18:0/20:1(11Z)), in particular, consists of one chain of plasmalogen 18:0 at the C-1 position and one chain of eicosenoic acid at the C-2 position. The plasmalogen 18:0 moiety is derived from animal fats, liver and kidney, while the eicosenoic acid moiety is derived from vegetable oils and cod oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PE(P-18:1(11Z)/20:0)

C43H84NO7P (757.5985083999999)

PE(P-18:1(11Z)/20:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(P-18:1(11Z)/20:0), in particular, consists of one chain of plasmalogen 18:1n7 at the C-1 position and one chain of arachidic acid at the C-2 position. The plasmalogen 18:1n7 moiety is derived from animal fats, liver and kidney, while the arachidic acid moiety is derived from peanut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.

PE(P-18:1(9Z)/20:0)

C43H84NO7P (757.5985083999999)

PE(P-18:1(9Z)/20:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(P-18:1(9Z)/20:0), in particular, consists of one chain of plasmalogen 18:1n9 at the C-1 position and one chain of arachidic acid at the C-2 position. The plasmalogen 18:1n9 moiety is derived from animal fats, liver and kidney, while the arachidic acid moiety is derived from peanut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PE(P-18:1(9Z)/20:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(P-18:1(9Z)/20:0), in particular, consists of one chain of plasmalogen 18:1n9 at the C-1 position and one chain of arachidic acid at the C-2 position. The plasmalogen 18:1n9 moiety is derived from animal fats, liver and kidney, while the arachidic acid moiety is derived from peanut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PE-NMe(16:1(9Z)/20:1(11Z))

C42H80NO8P (757.562125)

PE-NMe(16:1(9Z)/20:1(11Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(16:1(9Z)/20:1(11Z)), in particular, consists of one 9Z-hexadecenoyl chain to the C-1 atom, and one 11Z-eicosenoyl to the C-2 atom. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PE-NMe(18:1(9Z)/18:1(11Z))

C42H80NO8P (757.562125)

PE-NMe(18:1(9Z)/18:1(11Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(18:1(9Z)/18:1(11Z)), in particular, consists of one 9Z-octadecenoyl chain to the C-1 atom, and one 11Z-octadecenoyl to the C-2 atom. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PE-NMe(18:1(11Z)/18:1(9Z))

C42H80NO8P (757.562125)

PE-NMe(18:1(11Z)/18:1(9Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(18:1(11Z)/18:1(9Z)), in particular, consists of one 11Z-octadecenoyl chain to the C-1 atom, and one 9Z-octadecenoyl to the C-2 atom. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PE-NMe(18:1(11Z)/18:1(11Z))

C42H80NO8P (757.562125)

PE-NMe(18:1(11Z)/18:1(11Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(18:1(11Z)/18:1(11Z)), in particular, consists of two 11Z-octadecenoyl chain at positions C-1 and C2. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PE-NMe(14:0/22:2(13Z,16Z))

C42H80NO8P (757.562125)

PE-NMe(14:0/22:2(13Z,16Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(14:0/22:2(13Z,16Z)), in particular, consists of one chain of myristic acid at the C-1 position and one chain of docosadienoic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe(14:1(9Z)/22:1(13Z))

C42H80NO8P (757.562125)

PE-NMe(14:1(9Z)/22:1(13Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(14:1(9Z)/22:1(13Z)), in particular, consists of one chain of myristoleic acid at the C-1 position and one chain of erucic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe(16:0/20:2(11Z,14Z))

C42H80NO8P (757.562125)

PE-NMe(16:0/20:2(11Z,14Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(16:0/20:2(11Z,14Z)), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of eicosadienoic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe(18:0/18:2(9Z,12Z))

C42H80NO8P (757.562125)

PE-NMe(18:0/18:2(9Z,12Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(18:0/18:2(9Z,12Z)), in particular, consists of one chain of stearic acid at the C-1 position and one chain of linoleic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe(18:2(9Z,12Z)/18:0)

C42H80NO8P (757.562125)

PE-NMe(18:2(9Z,12Z)/18:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(18:2(9Z,12Z)/18:0), in particular, consists of one chain of linoleic acid at the C-1 position and one chain of stearic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe(20:1(11Z)/16:1(9Z))

C42H80NO8P (757.562125)

PE-NMe(20:1(11Z)/16:1(9Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(20:1(11Z)/16:1(9Z)), in particular, consists of one chain of eicosenoic acid at the C-1 position and one chain of palmitoleic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe(20:2(11Z,14Z)/16:0)

C42H80NO8P (757.562125)

PE-NMe(20:2(11Z,14Z)/16:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(20:2(11Z,14Z)/16:0), in particular, consists of one chain of eicosadienoic acid at the C-1 position and one chain of palmitic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe(22:1(13Z)/14:1(9Z))

C42H80NO8P (757.562125)

PE-NMe(22:1(13Z)/14:1(9Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(22:1(13Z)/14:1(9Z)), in particular, consists of one chain of erucic acid at the C-1 position and one chain of myristoleic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe(22:2(13Z,16Z)/14:0)

C42H80NO8P (757.562125)

PE-NMe(22:2(13Z,16Z)/14:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(22:2(13Z,16Z)/14:0), in particular, consists of one chain of docosadienoic acid at the C-1 position and one chain of myristic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe2(15:0/20:2(11Z,14Z))

C42H80NO8P (757.562125)

PE-NMe2(15:0/20:2(11Z,14Z)) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(15:0/20:2(11Z,14Z)), in particular, consists of one chain of pentadecanoic acid at the C-1 position and one chain of eicosadienoic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe2(20:2(11Z,14Z)/15:0)

C42H80NO8P (757.562125)

PE-NMe2(20:2(11Z,14Z)/15:0) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(20:2(11Z,14Z)/15:0), in particular, consists of one chain of eicosadienoic acid at the C-1 position and one chain of pentadecanoic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

Soybean lecithin

C42H80NO8P (757.562125)

PC(P-16:0/18:1(12Z)-O(9S,10R))

C42H80NO8P (757.562125)

PC(P-16:0/18:1(12Z)-O(9S,10R)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(P-16:0/18:1(12Z)-O(9S,10R)), in particular, consists of one chain of one 1Z-hexadecenyl at the C-1 position and one chain of 9,10-epoxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(18:1(12Z)-O(9S,10R)/P-16:0)

C42H80NO8P (757.562125)

PC(18:1(12Z)-O(9S,10R)/P-16:0) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(18:1(12Z)-O(9S,10R)/P-16:0), in particular, consists of one chain of one 9,10-epoxy-octadecenoyl at the C-1 position and one chain of 1Z-hexadecenyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(P-16:0/18:1(9Z)-O(12,13))

C42H80NO8P (757.562125)

PC(P-16:0/18:1(9Z)-O(12,13)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(P-16:0/18:1(9Z)-O(12,13)), in particular, consists of one chain of one 1Z-hexadecenyl at the C-1 position and one chain of 12,13-epoxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(18:1(9Z)-O(12,13)/P-16:0)

C42H80NO8P (757.562125)

PC(18:1(9Z)-O(12,13)/P-16:0) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(18:1(9Z)-O(12,13)/P-16:0), in particular, consists of one chain of one 12,13-epoxy-octadecenoyl at the C-1 position and one chain of 1Z-hexadecenyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

Phosphatidylcholine 16:0-18:2

C42H80NO8P (757.562125)

Phosphatidylcholine 16:1-18:1

C42H80NO8P (757.562125)

Phosphatidylethanolamine 19:0-18:2

C42H80NO8P (757.562125)

Phosphatidylethanolamine alkyl 20:0-18:2

C43H84NO7P (757.5985083999999)

Phosphatidylethanolamine alkyl 18:1-20:1

C43H84NO7P (757.5985083999999)

PC(16:1e/9-HODE)

C42H80NO8P (757.562125)

PC 34:2

C42H80NO8P (757.562125)

Found in mouse brain; TwoDicalId=253; MgfFile=160720_brain_DHA_14_Neg; MgfId=939 Found in mouse small intestine; TwoDicalId=9; MgfFile=160907_Small_Intestine_DHA_Neg_14; MgfId=1162

(2-{[3-(hexadecanoyloxy)-2-[octadeca-9.12-dienoyloxy]propyl phosphono]oxy}ethyl)trimethylazanium

C42H80NO8P (757.562125)

PC(16:0/18:2)

C42H80NO8P (757.562125)

PC(16:0/18:2)[U]

C42H80NO8P (757.562125)

PC(16:0/18:2)[S]

C42H80NO8P (757.562125)

PC(16:1/18:1)

C42H80NO8P (757.562125)

PC(16:1/18:1)[U]

C42H80NO8P (757.562125)

PC(17:1/17:1)[U]

C42H80NO8P (757.562125)

PC(17:1/17:1)

C42H80NO8P (757.562125)

PC(18:0/16:2)

C42H80NO8P (757.562125)

PC(18:1/16:1)[U]

C42H80NO8P (757.562125)

PC(18:2/16:0)

C42H80NO8P (757.562125)

PC(18:2/16:0)[U]

C42H80NO8P (757.562125)

PE-NMe(18:1/18:1)

C42H80NO8P (757.562125)

PE-NMe(18:1/18:1)[U]

C42H80NO8P (757.562125)

Lecithin

C42H80NO8P (757.562125)

Lecithin (/ˈlɛsɪθɪn/ LESS-ith-in; from the Ancient Greek λέκιθος lékithos "yolk") is a generic term to designate any group of yellow-brownish fatty substances occurring in animal and plant tissues which are amphiphilic – they attract both water and fatty substances (and so are both hydrophilic and lipophilic), and are used for smoothing food textures, emulsifying, homogenizing liquid mixtures, and repelling sticking materials.[1][2] Lecithins are mixtures of glycerophospholipids including phosphatidylcholine, phosphatidylethanolamine, phosphatidylinositol, phosphatidylserine, and phosphatidic acid.[3] Lecithin was first isolated in 1845 by the French chemist and pharmacist Théodore Gobley.[4] In 1850, he named the phosphatidylcholine lécithine.[5] Gobley originally isolated lecithin from egg yolk and established the complete chemical formula of phosphatidylcholine in 1874;[6] in between, he demonstrated the presence of lecithin in a variety of biological materials, including venous blood, human lungs, bile, roe, and brains of humans, sheep and chicken. Lecithin can easily be extracted chemically using solvents such as hexane, ethanol, acetone, petroleum ether or benzene; or extraction can be done mechanically. Common sources include egg yolk,[7] marine foods, soybeans,[7] milk, rapeseed, cottonseed, and sunflower oil. It has low solubility in water, but is an excellent emulsifier. In aqueous solution, its phospholipids can form either liposomes, bilayer sheets, micelles, or lamellar structures, depending on hydration and temperature. This results in a type of surfactant that usually is classified as amphipathic. Lecithin is sold as a food additive and dietary supplement. In cooking, it is sometimes used as an emulsifier and to prevent sticking, for example in non-stick cooking spray. D013501 - Surface-Active Agents > D054709 - Lecithins Lecithin is regarded as a safe, conventional phospholipid source. Phospholipids are reported to alter the fatty acid composition and microstructure of the membranes in animal cells. Lecithin is regarded as a safe, conventional phospholipid source. Phospholipids are reported to alter the fatty acid composition and microstructure of the membranes in animal cells.

PE(37:2)

C42H80NO8P (757.562125)

PE(38:1)

C43H84NO7P (757.5985083999999)

PC(12:0/22:2(13Z,16Z))

C42H80NO8P (757.562125)

PC(15:1(9Z)/19:1(9Z))

C42H80NO8P (757.562125)

PC(17:0/17:2(9Z,12Z))

C42H80NO8P (757.562125)

PC(17:2(9Z,12Z)/17:0)

C42H80NO8P (757.562125)

PC(19:1(9Z)/15:1(9Z))

C42H80NO8P (757.562125)

PC(22:2(13Z,16Z)/12:0)

C42H80NO8P (757.562125)

PE(15:1(9Z)/22:1(11Z))

C42H80NO8P (757.562125)

PE(17:0/20:2(11Z,14Z))

C42H80NO8P (757.562125)

PE(17:1(9Z)/20:1(11Z))

C42H80NO8P (757.562125)

PE(17:2(9Z,12Z)/20:0)

C42H80NO8P (757.562125)

PE(18:1(9Z)/19:1(9Z))

C42H80NO8P (757.562125)

PE(18:2(9Z,12Z)/19:0)

C42H80NO8P (757.562125)

PE(19:0/18:2(9Z,12Z))

C42H80NO8P (757.562125)

PE(19:1(9Z)/18:1(9Z))

C42H80NO8P (757.562125)

PE(20:0/17:2(9Z,12Z))

C42H80NO8P (757.562125)

PE(20:1(11Z)/17:1(9Z))

C42H80NO8P (757.562125)

PE(20:2(11Z,14Z)/17:0)

C42H80NO8P (757.562125)

PE(22:1(11Z)/15:1(9Z))

C42H80NO8P (757.562125)

1-(8-[5]-ladderane-octanyl)-2-(8-[3]-ladderane-octanyl)-sn-glycerophosphoethanolamine

C45H76NO6P (757.5409966)

PE-NMe 36:2

C42H80NO8P (757.562125)

PE 37:2

C42H80NO8P (757.562125)

PE dO-40:9

C45H76NO6P (757.5409966)

(2R)-2-[(9E,12E)-9,12-Octadecadienoyloxy]-3-(palmitoyloxy)propyl 2-(trimethylammonio)ethyl phosphate

C42H80NO8P (757.562125)

1-palmitoyl-2-linoleoyl-sn-glycero-3-phosphocholine

C42H80NO8P (757.562125)

DOTAP Mesylate

C43H83NO7S (757.5889927999999)

1-[(2Z)-hexadecenoyl]-2-[(9Z)-octadecenoyl]-sn-glycero-3-phosphocholine

C42H80NO8P (757.562125)

A phosphatidylcholine 34:2 in which the 1- and 2-acyl groups are specified as (2Z)-hexadecenoyl and (9Z)-octadecenoyl respectively.

N-Methyl-1,2-dioleoylphosphatidylethanolamine

C42H80NO8P (757.562125)

PC(P-16:0/18:1(12Z)-O(9S,10R))

C42H80NO8P (757.562125)

PC(18:1(12Z)-O(9S,10R)/P-16:0)

C42H80NO8P (757.562125)

PC(P-16:0/18:1(9Z)-O(12,13))

C42H80NO8P (757.562125)

PC(18:1(9Z)-O(12,13)/P-16:0)

C42H80NO8P (757.562125)

2-[[(E,2S,3R)-2-[[(8Z,11Z,14Z)-5,6-dihydroxyicosa-8,11,14-trienoyl]amino]-3-hydroxyhexadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C41H78N2O8P+ (757.5495498)

2-[hydroxy-[(2S,3R)-3-hydroxy-2-[[(10E,12Z)-9-oxooctadeca-10,12-dienoyl]amino]nonadecoxy]phosphoryl]oxyethyl-trimethylazanium

C42H82N2O7P+ (757.5859332)

2-[hydroxy-[(2S,3R)-3-hydroxy-2-[[(9Z,11E)-13-oxooctadeca-9,11-dienoyl]amino]nonadecoxy]phosphoryl]oxyethyl-trimethylazanium

C42H82N2O7P+ (757.5859332)

2-[hydroxy-[(2S,3R)-3-hydroxy-2-[[(10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoyl]amino]nonadecoxy]phosphoryl]oxyethyl-trimethylazanium

C42H82N2O7P+ (757.5859332)

2-[hydroxy-[(2S,3R)-3-hydroxy-2-[[(9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoyl]amino]nonadecoxy]phosphoryl]oxyethyl-trimethylazanium

C42H82N2O7P+ (757.5859332)

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-[8-[3-[(Z)-oct-2-enyl]oxiran-2-yl]octanoylamino]nonadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C42H82N2O7P+ (757.5859332)

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-[[(Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]amino]nonadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C42H82N2O7P+ (757.5859332)

(2R)-2,3-bis{[(9Z)-octadec-9-enoyl]oxy}propyl 2-(methylazaniumyl)ethyl phosphate

C42H80NO8P (757.562125)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-octadec-9-enoyl]oxypropan-2-yl] (Z)-nonadec-9-enoate

C42H80NO8P (757.562125)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-octadecanoyloxypropan-2-yl] (9Z,12Z)-nonadeca-9,12-dienoate

C42H80NO8P (757.562125)

Ldgcc 36:6

C46H79NO7 (757.5856223999999)

HexCer 9:1;2O/30:6

C45H75NO8 (757.5492390000001)

HexCer 9:0;2O/30:7

C45H75NO8 (757.5492390000001)

HexCer 17:3;2O/22:4

C45H75NO8 (757.5492390000001)

HexCer 15:2;2O/24:5

C45H75NO8 (757.5492390000001)

HexCer 19:3;2O/20:4

C45H75NO8 (757.5492390000001)

HexCer 13:2;2O/26:5

C45H75NO8 (757.5492390000001)

HexCer 21:2;2O/18:5

C45H75NO8 (757.5492390000001)

HexCer 19:2;2O/20:5

C45H75NO8 (757.5492390000001)

HexCer 23:3;2O/16:4

C45H75NO8 (757.5492390000001)

HexCer 21:3;2O/18:4

C45H75NO8 (757.5492390000001)

HexCer 13:1;2O/26:6

C45H75NO8 (757.5492390000001)

HexCer 11:0;2O/28:7

C45H75NO8 (757.5492390000001)

HexCer 15:1;2O/24:6

C45H75NO8 (757.5492390000001)

HexCer 17:1;2O/22:6

C45H75NO8 (757.5492390000001)

HexCer 17:2;2O/22:5

C45H75NO8 (757.5492390000001)

HexCer 15:3;2O/24:4

C45H75NO8 (757.5492390000001)

HexCer 11:1;2O/28:6

C45H75NO8 (757.5492390000001)

HexCer 13:0;2O/26:7

C45H75NO8 (757.5492390000001)

2-[2-[(8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-8,11,14,17,20,23-hexaenoyl]oxy-3-nonanoyloxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C45H75NO8 (757.5492390000001)

Lnape 24:1/N-13:1

C42H80NO8P (757.562125)

Lnape 19:0/N-18:2

C42H80NO8P (757.562125)

Lnape 19:1/N-18:1

C42H80NO8P (757.562125)

Lnape 11:0/N-26:2

C42H80NO8P (757.562125)

Lnape 26:2/N-11:0

C42H80NO8P (757.562125)

Lnape 18:1/N-19:1

C42H80NO8P (757.562125)

Lnape 15:0/N-22:2

C42H80NO8P (757.562125)

Lnape 22:1/N-15:1

C42H80NO8P (757.562125)

Lnape 22:2/N-15:0

C42H80NO8P (757.562125)

Lnape 13:1/N-24:1

C42H80NO8P (757.562125)

Lnape 17:1/N-20:1

C42H80NO8P (757.562125)

Lnape 15:1/N-22:1

C42H80NO8P (757.562125)

Lnape 18:0/N-19:2

C42H80NO8P (757.562125)

Lnape 20:0/N-17:2

C42H80NO8P (757.562125)

Lnape 21:0/N-16:2

C42H80NO8P (757.562125)

Lnape 20:1/N-17:1

C42H80NO8P (757.562125)

Lnape 18:2/N-19:0

C42H80NO8P (757.562125)

Lnape 17:0/N-20:2

C42H80NO8P (757.562125)

Lnape 17:2/N-20:0

C42H80NO8P (757.562125)

Lnape 16:2/N-21:0

C42H80NO8P (757.562125)

Lnape 21:2/N-16:0

C42H80NO8P (757.562125)

Lnape 16:0/N-21:2

C42H80NO8P (757.562125)

Lnape 19:2/N-18:0

C42H80NO8P (757.562125)

Lnape 21:1/N-16:1

C42H80NO8P (757.562125)

Lnape 24:2/N-13:0

C42H80NO8P (757.562125)

Lnape 13:0/N-24:2

C42H80NO8P (757.562125)

Lnape 16:1/N-21:1

C42H80NO8P (757.562125)

Lnape 20:2/N-17:0

C42H80NO8P (757.562125)

2-[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C45H75NO8 (757.5492390000001)

2-[2-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]oxy-3-[(Z)-tridec-9-enoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C45H75NO8 (757.5492390000001)

2-[2-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxy-3-[(Z)-pentadec-9-enoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C45H75NO8 (757.5492390000001)

2-[3-[(Z)-heptadec-9-enoyl]oxy-2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C45H75NO8 (757.5492390000001)

2-[2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-tridecanoyloxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C45H75NO8 (757.5492390000001)

2-[3-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C45H75NO8 (757.5492390000001)

2-[2-[(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoyl]oxy-3-undecanoyloxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C45H75NO8 (757.5492390000001)

HexCer 8:0;3O/28:2;(2OH)

C42H79NO10 (757.5703674)

HexCer 13:1;3O/23:1;(2OH)

C42H79NO10 (757.5703674)

HexCer 12:0;3O/24:2;(2OH)

C42H79NO10 (757.5703674)

HexCer 10:0;3O/26:2;(2OH)

C42H79NO10 (757.5703674)

HexCer 12:1;3O/24:1;(2OH)

C42H79NO10 (757.5703674)

(E)-2-[[(8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-8,11,14,17,20,23-hexaenoyl]amino]-3-hydroxyicos-4-ene-1-sulfonic acid

C46H79NO5S (757.5678644)

2-[[(5Z,8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-5,8,11,14,17,20,23-heptaenoyl]amino]-3-hydroxyicosane-1-sulfonic acid

C46H79NO5S (757.5678644)

(4E,8E,12E)-2-[[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoyl]amino]-3-hydroxyicosa-4,8,12-triene-1-sulfonic acid

C46H79NO5S (757.5678644)

(4E,8E)-3-hydroxy-2-[[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]amino]hexacosa-4,8-diene-1-sulfonic acid

C46H79NO5S (757.5678644)

(4E,8E)-2-[[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]amino]-3-hydroxytetracosa-4,8-diene-1-sulfonic acid

C46H79NO5S (757.5678644)

(4E,8E,12E)-2-[[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]amino]-3-hydroxytetracosa-4,8,12-triene-1-sulfonic acid

C46H79NO5S (757.5678644)

(E)-2-[[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]amino]-3-hydroxytetracos-4-ene-1-sulfonic acid

C46H79NO5S (757.5678644)

(4E,8E)-2-[[(11Z,14Z,17Z,20Z,23Z)-hexacosa-11,14,17,20,23-pentaenoyl]amino]-3-hydroxyicosa-4,8-diene-1-sulfonic acid

C46H79NO5S (757.5678644)

(4E,8E)-3-hydroxy-2-[[(9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoyl]amino]docosa-4,8-diene-1-sulfonic acid

C46H79NO5S (757.5678644)

(E)-3-hydroxy-2-[[(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoyl]amino]docos-4-ene-1-sulfonic acid

C46H79NO5S (757.5678644)

(4E,8E,12E)-3-hydroxy-2-[[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoyl]amino]docosa-4,8,12-triene-1-sulfonic acid

C46H79NO5S (757.5678644)

(4E,8E,12E)-3-hydroxy-2-[[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]amino]hexacosa-4,8,12-triene-1-sulfonic acid

C46H79NO5S (757.5678644)

OxPC 34:3e+1O

C42H80NO8P (757.562125)

4-[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-[(Z)-icos-11-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

4-[2-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]oxy-3-tetradecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

4-[3-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-2-[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

4-[2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-[(11Z,14Z)-icosa-11,14-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

4-[2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxy-3-[(Z)-octadec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

4-[3-hexadecanoyloxy-2-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

4-[3-[(9Z,12Z)-octadeca-9,12-dienoyl]oxy-2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

4-[2-[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]oxy-3-[(Z)-tetradec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

4-[3-[(Z)-hexadec-9-enoyl]oxy-2-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

4-[3-octadecanoyloxy-2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

HexCer 18:1;3O/18:1;(2OH)

C42H79NO10 (757.5703674)

HexCer 16:2;3O/20:0;(2OH)

C42H79NO10 (757.5703674)

HexCer 14:0;3O/22:2;(2OH)

C42H79NO10 (757.5703674)

HexCer 14:2;3O/22:0;(2OH)

C42H79NO10 (757.5703674)

HexCer 15:2;3O/21:0;(2OH)

C42H79NO10 (757.5703674)

HexCer 21:1;3O/15:1;(2OH)

C42H79NO10 (757.5703674)

HexCer 17:1;3O/19:1;(2OH)

C42H79NO10 (757.5703674)

HexCer 18:0;3O/18:2;(2OH)

C42H79NO10 (757.5703674)

HexCer 22:1;3O/14:1;(2OH)

C42H79NO10 (757.5703674)

HexCer 21:2;3O/15:0;(2OH)

C42H79NO10 (757.5703674)

HexCer 17:2;3O/19:0;(2OH)

C42H79NO10 (757.5703674)

HexCer 14:1;3O/22:1;(2OH)

C42H79NO10 (757.5703674)

HexCer 24:2;3O/12:0;(2OH)

C42H79NO10 (757.5703674)

HexCer 16:1;3O/20:1;(2OH)

C42H79NO10 (757.5703674)

HexCer 15:1;3O/21:1;(2OH)

C42H79NO10 (757.5703674)

HexCer 19:2;3O/17:0;(2OH)

C42H79NO10 (757.5703674)

HexCer 20:2;3O/16:0;(2OH)

C42H79NO10 (757.5703674)

HexCer 22:2;3O/14:0;(2OH)

C42H79NO10 (757.5703674)

HexCer 18:2;3O/18:0;(2OH)

C42H79NO10 (757.5703674)

HexCer 16:0;3O/20:2;(2OH)

C42H79NO10 (757.5703674)

HexCer 20:1;3O/16:1;(2OH)

C42H79NO10 (757.5703674)

HexCer 24:1;3O/12:1;(2OH)

C42H79NO10 (757.5703674)

HexCer 23:1;3O/13:1;(2OH)

C42H79NO10 (757.5703674)

HexCer 23:2;3O/13:0;(2OH)

C42H79NO10 (757.5703674)

HexCer 20:0;3O/16:2;(2OH)

C42H79NO10 (757.5703674)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-nonanoyloxypropan-2-yl] (17Z,20Z)-octacosa-17,20-dienoate

C42H80NO8P (757.562125)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-hexadec-9-enoyl]oxypropan-2-yl] (Z)-henicos-11-enoate

C42H80NO8P (757.562125)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-undecanoyloxypropan-2-yl] (15Z,18Z)-hexacosa-15,18-dienoate

C42H80NO8P (757.562125)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-pentadec-9-enoyl]oxypropan-2-yl] (Z)-docos-13-enoate

C42H80NO8P (757.562125)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxypropyl] icosanoate

C42H80NO8P (757.562125)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecanoyloxypropan-2-yl] (13Z,16Z)-tetracosa-13,16-dienoate

C42H80NO8P (757.562125)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxypropyl] henicosanoate

C42H80NO8P (757.562125)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecanoyloxypropan-2-yl] (11Z,14Z)-icosa-11,14-dienoate

C42H80NO8P (757.562125)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropyl] nonadecanoate

C42H80NO8P (757.562125)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tridec-9-enoyl]oxypropan-2-yl] (Z)-tetracos-13-enoate

C42H80NO8P (757.562125)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] (11Z,14Z)-henicosa-11,14-dienoate

C42H80NO8P (757.562125)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-heptadec-9-enoyl]oxypropan-2-yl] (Z)-icos-11-enoate

C42H80NO8P (757.562125)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecanoyloxypropan-2-yl] (13Z,16Z)-docosa-13,16-dienoate

C42H80NO8P (757.562125)

[3-[(Z)-hexadec-9-enoyl]oxy-2-[(Z)-octadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H80NO8P (757.562125)

[3-decanoyloxy-2-[(13Z,16Z)-tetracosa-13,16-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H80NO8P (757.562125)

[2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-3-tridecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H80NO8P (757.562125)

[2-[(Z)-nonadec-9-enoyl]oxy-3-[(Z)-pentadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H80NO8P (757.562125)

[2-[(11Z,14Z)-icosa-11,14-dienoyl]oxy-3-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H80NO8P (757.562125)

[2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxy-3-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H80NO8P (757.562125)

[2-[(Z)-icos-11-enoyl]oxy-3-[(Z)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H80NO8P (757.562125)

[2-[(15Z,18Z)-hexacosa-15,18-dienoyl]oxy-3-octanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H80NO8P (757.562125)

2,3-bis[[(Z)-heptadec-9-enoyl]oxy]propyl 2-(trimethylazaniumyl)ethyl phosphate

C42H80NO8P (757.562125)

[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-heptadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H80NO8P (757.562125)

[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-octadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H80NO8P (757.562125)

[2-[(Z)-henicos-11-enoyl]oxy-3-[(Z)-tridec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H80NO8P (757.562125)

[2-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-3-dodecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H80NO8P (757.562125)

[(2R)-3-[(E)-hexadec-7-enoyl]oxy-2-octadec-17-enoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H80NO8P (757.562125)

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-heptadec-9-enoyl]oxypropyl] (E)-icos-11-enoate

C42H80NO8P (757.562125)

4-[3-[(9E,11E)-henicosa-9,11-dienoyl]oxy-2-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

[(2R)-3-[(E)-hexadec-9-enoyl]oxy-2-[(E)-octadec-6-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H80NO8P (757.562125)

[(2R)-2-[(E)-icos-13-enoyl]oxy-3-[(E)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H80NO8P (757.562125)

[(2R)-3-[(E)-hexadec-7-enoyl]oxy-2-[(E)-octadec-7-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H80NO8P (757.562125)

[(2R)-2-[(E)-hexadec-7-enoyl]oxy-3-[(E)-octadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H80NO8P (757.562125)

4-[2-[(13E,16E,19E)-docosa-13,16,19-trienoyl]oxy-3-[(7E,9E)-tetradeca-7,9-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(6E,9E)-octadeca-6,9-dienoyl]oxypropan-2-yl] nonadecanoate

C42H80NO8P (757.562125)

[(2R)-3-[(E)-hexadec-9-enoyl]oxy-2-[(E)-octadec-4-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H80NO8P (757.562125)

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-heptadecanoyloxypropyl] (11E,14E)-icosa-11,14-dienoate

C42H80NO8P (757.562125)

[(2R)-2-[(E)-hexadec-9-enoyl]oxy-3-[(E)-octadec-4-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H80NO8P (757.562125)

4-[3-[(9E,11E,13E,15E)-henicosa-9,11,13,15-tetraenoyl]oxy-2-[(E)-pentadec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

4-[2-[(11E,14E)-heptadeca-11,14-dienoyl]oxy-3-[(10E,13E,16E)-nonadeca-10,13,16-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

[(2R)-2-[(E)-hexadec-7-enoyl]oxy-3-[(E)-octadec-6-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H80NO8P (757.562125)

4-[3-[(7E,10E,13E,16E,19E)-docosa-7,10,13,16,19-pentaenoyl]oxy-2-tetradecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(9E,11E)-octadeca-9,11-dienoyl]oxypropyl] nonadecanoate

C42H80NO8P (757.562125)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-pentadec-9-enoyl]oxypropan-2-yl] (E)-docos-13-enoate

C42H80NO8P (757.562125)

4-[2-heptadecanoyloxy-3-[(4E,7E,10E,13E,16E)-nonadeca-4,7,10,13,16-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

[(2R)-2-[(E)-hexadec-9-enoyl]oxy-3-octadec-17-enoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H80NO8P (757.562125)

4-[3-[(9E,11E,13E,15E,17E)-henicosa-9,11,13,15,17-pentaenoyl]oxy-2-pentadecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

4-[2-[(7E,10E,13E,16E,19E)-docosa-7,10,13,16,19-pentaenoyl]oxy-3-tetradecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

[2-[(4E,7E)-hexadeca-4,7-dienoyl]oxy-3-octadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H80NO8P (757.562125)

4-[2-[(9E,11E,13E,15E,17E)-henicosa-9,11,13,15,17-pentaenoyl]oxy-3-pentadecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

4-[2-[(E)-dec-4-enoyl]oxy-3-[(14E,17E,20E,23E)-hexacosa-14,17,20,23-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

4-[2-[(10E,12E)-octadeca-10,12-dienoyl]oxy-3-[(11E,13E,15E)-octadeca-11,13,15-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

[(2R)-2-[(E)-hexadec-9-enoyl]oxy-3-[(E)-octadec-11-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H80NO8P (757.562125)

[(2S)-3-[(E)-icos-11-enoyl]oxy-2-[(E)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H80NO8P (757.562125)

4-[2-[(11E,14E,17E,20E)-tricosa-11,14,17,20-tetraenoyl]oxy-3-[(E)-tridec-8-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

[(2R)-2-hexadecanoyloxy-3-[(9E,12E)-octadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H80NO8P (757.562125)

4-[3-[(9E,11E,13E)-henicosa-9,11,13-trienoyl]oxy-2-[(9E,12E)-pentadeca-9,12-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

4-[2-decanoyloxy-3-[(11E,14E,17E,20E,23E)-hexacosa-11,14,17,20,23-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9E,11E)-octadeca-9,11-dienoyl]oxypropan-2-yl] nonadecanoate

C42H80NO8P (757.562125)

4-[3-[(13E,16E,19E)-docosa-13,16,19-trienoyl]oxy-2-[(7E,9E)-tetradeca-7,9-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

[(2R)-2-[(E)-hexadec-7-enoyl]oxy-3-[(E)-octadec-7-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H80NO8P (757.562125)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecanoyloxypropan-2-yl] (5E,8E)-icosa-5,8-dienoate

C42H80NO8P (757.562125)

4-[3-decanoyloxy-2-[(11E,14E,17E,20E,23E)-hexacosa-11,14,17,20,23-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

4-[3-[(4E,7E)-deca-4,7-dienoyl]oxy-2-[(17E,20E,23E)-hexacosa-17,20,23-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-undecanoyloxypropyl] (5E,9E)-hexacosa-5,9-dienoate

C42H80NO8P (757.562125)

4-[3-[(11E,14E,17E,20E)-tricosa-11,14,17,20-tetraenoyl]oxy-2-[(E)-tridec-8-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-pentadec-9-enoyl]oxypropyl] (E)-docos-13-enoate

C42H80NO8P (757.562125)

[(2R)-2-[(11E,14E)-icosa-11,14-dienoyl]oxy-3-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H80NO8P (757.562125)

[(2R)-3-[(E)-hexadec-7-enoyl]oxy-2-[(E)-octadec-6-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H80NO8P (757.562125)

[(2S)-3-[(13E,16E)-docosa-13,16-dienoyl]oxy-2-dodecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H80NO8P (757.562125)

[(2R)-2-[(E)-hexadec-7-enoyl]oxy-3-octadec-17-enoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H80NO8P (757.562125)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-undecanoyloxypropan-2-yl] (5E,9E)-hexacosa-5,9-dienoate

C42H80NO8P (757.562125)

[(2S)-3-[(11E,14E)-icosa-11,14-dienoyl]oxy-2-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H80NO8P (757.562125)

4-[2-dodecanoyloxy-3-[(6E,9E,12E,15E,18E)-tetracosa-6,9,12,15,18-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

4-[2-[(9E,11E)-henicosa-9,11-dienoyl]oxy-3-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

[(2R)-3-[(E)-hexadec-9-enoyl]oxy-2-[(E)-octadec-11-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H80NO8P (757.562125)

[(2R)-2-[(E)-hexadec-7-enoyl]oxy-3-[(E)-octadec-4-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H80NO8P (757.562125)

4-[2-[(E)-hexadec-7-enoyl]oxy-3-[(5E,8E,11E,14E)-icosa-5,8,11,14-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

4-[2-[(4E,7E)-deca-4,7-dienoyl]oxy-3-[(17E,20E,23E)-hexacosa-17,20,23-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-pentadecanoyloxypropyl] (13E,16E)-docosa-13,16-dienoate

C42H80NO8P (757.562125)

[(2R)-3-[(E)-hexadec-9-enoyl]oxy-2-octadec-17-enoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H80NO8P (757.562125)

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(9E,12E)-heptadeca-9,12-dienoyl]oxypropyl] icosanoate

C42H80NO8P (757.562125)

[(2R)-3-[(E)-hexadec-9-enoyl]oxy-2-[(E)-octadec-7-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H80NO8P (757.562125)

4-[2-hexadecanoyloxy-3-[(5E,8E,11E,14E,17E)-icosa-5,8,11,14,17-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

[(2R)-2-[(E)-hexadec-9-enoyl]oxy-3-[(E)-octadec-7-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H80NO8P (757.562125)

4-[2-[(6E,9E)-dodeca-6,9-dienoyl]oxy-3-[(15E,18E,21E)-tetracosa-15,18,21-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

[(2R)-2-[(E)-hexadec-7-enoyl]oxy-3-[(E)-octadec-13-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H80NO8P (757.562125)

[(2R)-2-[(5E,8E)-icosa-5,8-dienoyl]oxy-3-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H80NO8P (757.562125)

[(2R)-2-[(E)-hexadec-9-enoyl]oxy-3-[(E)-octadec-6-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H80NO8P (757.562125)

4-[3-[(E)-hexadec-7-enoyl]oxy-2-[(5E,8E,11E,14E)-icosa-5,8,11,14-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

4-[3-[(9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoyl]oxy-2-[(E)-octadec-11-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

4-[3-[(13E,16E,19E,22E)-pentacosa-13,16,19,22-tetraenoyl]oxy-2-[(E)-undec-4-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

[(2R)-3-hexadecanoyloxy-2-[(6E,9E)-octadeca-6,9-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H80NO8P (757.562125)

[(2R)-3-[(E)-hexadec-7-enoyl]oxy-2-[(E)-octadec-4-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H80NO8P (757.562125)

4-[3-[(14E,16E)-docosa-14,16-dienoyl]oxy-2-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

[(2R)-2-[(E)-icos-11-enoyl]oxy-3-[(E)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H80NO8P (757.562125)

4-[2-[(14E,16E)-docosa-14,16-dienoyl]oxy-3-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

4-[2-[(8E,11E,14E)-heptadeca-8,11,14-trienoyl]oxy-3-[(7E,9E)-nonadeca-7,9-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

4-[3-[(8E,11E,14E)-heptadeca-8,11,14-trienoyl]oxy-2-[(7E,9E)-nonadeca-7,9-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

4-[3-hexadecanoyloxy-2-[(5E,8E,11E,14E,17E)-icosa-5,8,11,14,17-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

[(2S)-3-[(E)-icos-13-enoyl]oxy-2-[(E)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H80NO8P (757.562125)

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(6E,9E)-octadeca-6,9-dienoyl]oxypropyl] nonadecanoate

C42H80NO8P (757.562125)

4-[3-[(E)-dec-4-enoyl]oxy-2-[(14E,17E,20E,23E)-hexacosa-14,17,20,23-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(4E,7E)-hexadeca-4,7-dienoyl]oxypropyl] henicosanoate

C42H80NO8P (757.562125)

4-[2-[(9E,11E,13E,15E)-henicosa-9,11,13,15-tetraenoyl]oxy-3-[(E)-pentadec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

4-[2-[(8E,11E,14E,17E,20E)-tricosa-8,11,14,17,20-pentaenoyl]oxy-3-tridecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

4-[3-heptadecanoyloxy-2-[(4E,7E,10E,13E,16E)-nonadeca-4,7,10,13,16-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecanoyloxypropan-2-yl] (11E,14E)-icosa-11,14-dienoate

C42H80NO8P (757.562125)

4-[3-[(E)-heptadec-7-enoyl]oxy-2-[(7E,10E,13E,16E)-nonadeca-7,10,13,16-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

[(2R)-3-[(E)-hexadec-7-enoyl]oxy-2-[(E)-octadec-11-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H80NO8P (757.562125)

[(2R)-2-[(E)-hexadec-9-enoyl]oxy-3-[(E)-octadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H80NO8P (757.562125)

4-[2-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxy-3-[(11E,14E)-icosa-11,14-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

[(2R)-3-[(E)-hexadec-7-enoyl]oxy-2-[(E)-octadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H80NO8P (757.562125)

4-[3-[(10E,12E)-octadeca-10,12-dienoyl]oxy-2-[(11E,13E,15E)-octadeca-11,13,15-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

[(2R)-3-[(E)-hexadec-7-enoyl]oxy-2-[(E)-octadec-13-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H80NO8P (757.562125)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9E,12E)-heptadeca-9,12-dienoyl]oxypropan-2-yl] icosanoate

C42H80NO8P (757.562125)

[(2R)-2,3-bis[[(E)-heptadec-9-enoyl]oxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H80NO8P (757.562125)

[(2R)-3-[(9E,12E)-heptadeca-9,12-dienoyl]oxy-2-heptadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H80NO8P (757.562125)

4-[3-[(4E,7E)-hexadeca-4,7-dienoyl]oxy-2-[(5E,8E,11E)-icosa-5,8,11-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(9E,12E)-octadeca-9,12-dienoyl]oxypropyl] nonadecanoate

C42H80NO8P (757.562125)

[(2S)-3-[(5E,8E)-icosa-5,8-dienoyl]oxy-2-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H80NO8P (757.562125)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-heptadec-9-enoyl]oxypropan-2-yl] (E)-icos-13-enoate

C42H80NO8P (757.562125)

[(2R)-2-[(E)-hexadec-9-enoyl]oxy-3-[(E)-octadec-13-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H80NO8P (757.562125)

[(2R)-2-[(9E,12E)-heptadeca-9,12-dienoyl]oxy-3-heptadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H80NO8P (757.562125)

[(2R)-3-[(E)-hexadec-9-enoyl]oxy-2-[(E)-octadec-13-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H80NO8P (757.562125)

[(2R)-2-hexadecanoyloxy-3-[(6E,9E)-octadeca-6,9-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H80NO8P (757.562125)

4-[2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-icosanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

4-[2-[(E)-heptadec-7-enoyl]oxy-3-[(7E,10E,13E,16E)-nonadeca-7,10,13,16-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

4-[2-[(4E,7E)-hexadeca-4,7-dienoyl]oxy-3-[(5E,8E,11E)-icosa-5,8,11-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

4-[3-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxy-2-[(11E,14E)-icosa-11,14-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

4-[2-[(13E,16E,19E,22E)-pentacosa-13,16,19,22-tetraenoyl]oxy-3-[(E)-undec-4-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

4-[2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-[(E)-icos-11-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

4-[2-[(10E,13E,16E,19E,22E)-pentacosa-10,13,16,19,22-pentaenoyl]oxy-3-undecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-heptadecanoyloxypropyl] (5E,8E)-icosa-5,8-dienoate

C42H80NO8P (757.562125)

4-[2-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-3-[(18E,21E)-tetracosa-18,21-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

4-[3-dodecanoyloxy-2-[(6E,9E,12E,15E,18E)-tetracosa-6,9,12,15,18-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(2E,4E)-octadeca-2,4-dienoyl]oxypropyl] nonadecanoate

C42H80NO8P (757.562125)

4-[3-[(6E,9E)-dodeca-6,9-dienoyl]oxy-2-[(15E,18E,21E)-tetracosa-15,18,21-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

4-[2-[(10E,13E,16E,19E)-docosa-10,13,16,19-tetraenoyl]oxy-3-[(E)-tetradec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9E,12E)-octadeca-9,12-dienoyl]oxypropan-2-yl] nonadecanoate

C42H80NO8P (757.562125)

4-[3-octadecanoyloxy-2-[(7E,9E,11E,13E,15E)-octadeca-7,9,11,13,15-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

[(2R)-2-[(E)-hexadec-7-enoyl]oxy-3-[(E)-octadec-11-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H80NO8P (757.562125)

[(2R)-2-hexadecanoyloxy-3-[(9E,11E)-octadeca-9,11-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H80NO8P (757.562125)

4-[2-[(E)-dodec-5-enoyl]oxy-3-[(9E,12E,15E,18E)-tetracosa-9,12,15,18-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

[(2R)-2-[(13E,16E)-docosa-13,16-dienoyl]oxy-3-dodecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H80NO8P (757.562125)

4-[3-[(11E,14E)-heptadeca-11,14-dienoyl]oxy-2-[(10E,13E,16E)-nonadeca-10,13,16-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

4-[2-octadecanoyloxy-3-[(7E,9E,11E,13E,15E)-octadeca-7,9,11,13,15-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

4-[3-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-2-[(18E,21E)-tetracosa-18,21-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-heptadec-9-enoyl]oxypropan-2-yl] (E)-icos-11-enoate

C42H80NO8P (757.562125)

4-[3-[(10E,13E,16E,19E,22E)-pentacosa-10,13,16,19,22-pentaenoyl]oxy-2-undecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

4-[3-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-2-icosanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

4-[2-[(9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoyl]oxy-3-[(E)-octadec-11-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

4-[2-[(9E,11E,13E)-henicosa-9,11,13-trienoyl]oxy-3-[(9E,12E)-pentadeca-9,12-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

4-[3-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-2-[(E)-icos-11-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

4-[3-[(8E,11E,14E,17E,20E)-tricosa-8,11,14,17,20-pentaenoyl]oxy-2-tridecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecanoyloxypropan-2-yl] (13E,16E)-docosa-13,16-dienoate

C42H80NO8P (757.562125)

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-heptadec-9-enoyl]oxypropyl] (E)-icos-13-enoate

C42H80NO8P (757.562125)

4-[3-[(E)-dodec-5-enoyl]oxy-2-[(9E,12E,15E,18E)-tetracosa-9,12,15,18-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(2E,4E)-octadeca-2,4-dienoyl]oxypropan-2-yl] nonadecanoate

C42H80NO8P (757.562125)

[(2R)-3-[(E)-hexadec-9-enoyl]oxy-2-[(E)-octadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H80NO8P (757.562125)

4-[3-[(10E,13E,16E,19E)-docosa-10,13,16,19-tetraenoyl]oxy-2-[(E)-tetradec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C46H79NO7 (757.5856223999999)

2-[hydroxy-[(E)-3-hydroxy-2-[[(6Z,9Z,12Z,15Z,18Z,21Z,24Z,27Z)-triaconta-6,9,12,15,18,21,24,27-octaenoyl]amino]non-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C44H74N2O6P+ (757.5284214000001)

2-[[(4E,8E,12E)-2-[[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]amino]-3-hydroxyheptadeca-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C44H74N2O6P+ (757.5284214000001)

2-[[(E)-3,4-dihydroxy-2-[[(9Z,12Z)-nonadeca-9,12-dienoyl]amino]octadec-8-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C42H82N2O7P+ (757.5859332)

2-[[(4E,8E)-2-[[(5Z,8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-5,8,11,14,17,20,23-heptaenoyl]amino]-3-hydroxytrideca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C44H74N2O6P+ (757.5284214000001)

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-[[(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoyl]amino]pentadeca-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

C44H74N2O6P+ (757.5284214000001)

2-[[(8E,12E,16E)-3,4-dihydroxy-2-(nonadecanoylamino)octadeca-8,12,16-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C42H82N2O7P+ (757.5859332)

2-[[(8E,12E)-3,4-dihydroxy-2-[[(Z)-nonadec-9-enoyl]amino]octadeca-8,12-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C42H82N2O7P+ (757.5859332)

1-[(9Z,12Z)-octadecadienoyl]-2-hexadecanoyl-sn-glycero-3-phosphocholine

C42H80NO8P (757.562125)

A phosphatidylcholine 34:2 in which the acyl groups specified at positions 1 and 2 are (9Z,12Z)-octadecadienoyl and linoleoyl respectively.

PC(18:1(11Z)/16:1(9Z))

C42H80NO8P (757.562125)

1-[(9Z)-hexadecenoyl]-2-[(9Z)-octadecenoyl]-sn-glycero-3-phosphocholine

C42H80NO8P (757.562125)

A phosphatidylcholine 34:2 in which the 1- and 2-acyl groups are specified as (9Z)-hexadecenoyl (palmitoleoyl) and (9Z)-octadecenoyl (oleoyl) respectively.

1-tetradecanoyl-2-(11Z,14Z-eicosadienoyl)-glycero-3-phosphocholine

C42H80NO8P (757.562125)

PC(14:1(9Z)/20:1(11Z))

C42H80NO8P (757.562125)

1-(11Z-eicosenoyl)-2-(9Z-tetradecenoyl)-glycero-3-phosphocholine

C42H80NO8P (757.562125)

PC(20:2(11Z,14Z)/14:0)

C42H80NO8P (757.562125)

1-[(9Z)-octadecenoyl]-2-[(9Z)-hexadecenoyl]-sn-glycero-3-phosphocholine

C42H80NO8P (757.562125)

A phosphatidylcholine 34:2 in which the acyl groups specified at positions 1 and 2 are (9Z)-octadecenoyl and (9Z)-hexadecenoyl respectively.

1-[(9Z)-hexadecenoyl]-2-[(11Z)-octadecenoyl]-sn-glycero-3-phosphocholine

C42H80NO8P (757.562125)

A phosphatidylcholine 34:2 in which the 1- and 2-acyl groups are specified as (9Z)-hexadecenoyl and (11Z)-octadecenoyl respectively.

PE-NMe(18:1(9Z)/18:1(9Z))

C42H80NO8P (757.562125)

1-pentadecanoyl-2-(13Z,16Z-docosadienoyl)-glycero-3-phosphoethanolamine

C42H80NO8P (757.562125)

1-(13Z,16Z-docosadienoyl)-2-pentadecanoyl-glycero-3-phosphoethanolamine

C42H80NO8P (757.562125)

PE-NMe(18:0/18:2(9Z,12Z))

C42H80NO8P (757.562125)

PE-NMe(18:2(9Z,12Z)/18:0)

C42H80NO8P (757.562125)

PE-NMe(16:1(9Z)/20:1(11Z))

C42H80NO8P (757.562125)

PE-NMe(18:1(9Z)/18:1(11Z))

C42H80NO8P (757.562125)

PE-NMe(18:1(11Z)/18:1(9Z))

C42H80NO8P (757.562125)

PE-NMe(14:0/22:2(13Z,16Z))

C42H80NO8P (757.562125)

PE-NMe(14:1(9Z)/22:1(13Z))

C42H80NO8P (757.562125)

PE-NMe(16:0/20:2(11Z,14Z))

C42H80NO8P (757.562125)

PE-NMe(20:1(11Z)/16:1(9Z))

C42H80NO8P (757.562125)

PE-NMe(20:2(11Z,14Z)/16:0)

C42H80NO8P (757.562125)

PE-NMe(22:1(13Z)/14:1(9Z))

C42H80NO8P (757.562125)

PE-NMe(22:2(13Z,16Z)/14:0)

C42H80NO8P (757.562125)

PE-NMe(18:1(11Z)/18:1(11Z))

C42H80NO8P (757.562125)

PE-NMe2(15:0/20:2(11Z,14Z))

C42H80NO8P (757.562125)

PE-NMe2(20:2(11Z,14Z)/15:0)

C42H80NO8P (757.562125)

1,2-dioleoyl-sn-glycero-3-phospho-N-methylethanolamine zwitterion

C42H80NO8P (757.562125)

A 1,2-diacyl-sn-glycero-3-phospho-N-methylethanolamine zwitterion in which the phosphatidyl acyl groups are both specified as oleoyl (9Z-octadecenoyl); major species at pH 7.3.

1-hexadecanoyl-2-(6Z,9Z-octadecadienoyl)-sn-glycero-3-phosphocholine

C42H80NO8P (757.562125)

1-(9Z-octadecenoyl)-2-(9Z-nonadecenoyl)-glycero-3-phosphoethanolamine

C42H80NO8P (757.562125)

1-nonadecanoyl-2-(9Z,12Z-octadecadienoyl)-glycero-3-phosphoethanolamine

C42H80NO8P (757.562125)

1-hexadecanoyl-2-(2Z,4Z-octadecadienoyl)-sn-glycero-3-phosphocholine

C42H80NO8P (757.562125)

1-octadecanoyl-2-(2E,4E-hexadecadienoyl)-sn-glycero-3-phosphocholine

C42H80NO8P (757.562125)

1-hexadecanoyl-2-(11Z,13Z-octadecadienoyl)-sn-glycero-3-phosphocholine

C42H80NO8P (757.562125)

1-hexadecanoyl-2-(2E,4E-octadecadienoyl)-sn-glycero-3-phosphocholine

C42H80NO8P (757.562125)

1-(2E,4E-octadecadienoyl)-2-hexadecanoyl-sn-glycero-3-phosphocholine

C42H80NO8P (757.562125)

1-(6Z,9Z-octadecadienoyl)-2-hexadecanoyl-sn-glycero-3-phosphocholine

C42H80NO8P (757.562125)

1-hexadecanoyl-2-(9E,11E-octadecadienoyl)-sn-glycero-3-phosphocholine

C42H80NO8P (757.562125)

1-(9Z-pentadecenoyl)-2-(9Z-nonadecenoyl)-glycero-3-phosphocholine

C42H80NO8P (757.562125)

1-(9Z,12Z-heptadecadienoyl)-2-heptadecanoyl-glycero-3-phosphocholine

C42H80NO8P (757.562125)

1-(9Z-nonadecenoyl)-2-(9Z-octadecenoyl)-glycero-3-phosphoethanolamine

C42H80NO8P (757.562125)

1-hexadecanoyl-2-(9E,11Z-octadecadienoyl)-sn-glycero-3-phosphocholine

C42H80NO8P (757.562125)

1,2-di-(9Z-heptadecenoyl)-sn-glycero-3-phosphocholine

C42H80NO8P (757.562125)

1-heptadecanoyl-2-(9Z,12Z-heptadecadienoyl)-glycero-3-phosphocholine

C42H80NO8P (757.562125)

1-(9Z-nonadecenoyl)-2-(9Z-pentadecenoyl)-glycero-3-phosphocholine

C42H80NO8P (757.562125)

1-(9Z,12Z-heptadecadienoyl)-2-eicosanoyl-glycero-3-phosphoethanolamine

C42H80NO8P (757.562125)

1-(9Z,12Z-octadecadienoyl)-2-nonadecanoyl-glycero-3-phosphoethanolamine

C42H80NO8P (757.562125)

1-eicosanoyl-2-(9Z,12Z-heptadecadienoyl)-glycero-3-phosphoethanolamine

C42H80NO8P (757.562125)

1-hexadecanoyl-2-(10E,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine

C42H80NO8P (757.562125)

1-dodecanoyl-2-(13Z,16Z-docosadienoyl)-glycero-3-phosphocholine

C42H80NO8P (757.562125)

1-(9Z-pentadecenoyl)-2-(11Z-docosenoyl)-glycero-3-phosphoethanolamine

C42H80NO8P (757.562125)

1-(11Z-docosenoyl)-2-(9Z-pentadecenoyl)-glycero-3-phosphoethanolamine

C42H80NO8P (757.562125)

1-(13Z,16Z-docosadienoyl)-2-dodecanoyl-glycero-3-phosphocholine

C42H80NO8P (757.562125)

1-heptadecanoyl-2-(11Z,14Z-eicosadienoyl)-glycero-3-phosphoethanolamine

C42H80NO8P (757.562125)

1-(9Z-heptadecenoyl)-2-(11Z-eicosenoyl)-glycero-3-phosphoethanolamine

C42H80NO8P (757.562125)

1-(11Z-eicosenoyl)-2-(9Z-heptadecenoyl)-glycero-3-phosphoethanolamine

C42H80NO8P (757.562125)

1-(11Z,14Z-eicosadienoyl)-2-heptadecanoyl-glycero-3-phosphoethanolamine

C42H80NO8P (757.562125)

1,2-di-(10Z-heptadecenoyl)-sn-glycero-3-phosphocholine

C42H80NO8P (757.562125)

phosphatidylethanolamine 37:2 zwitterion

C42H80NO8P (757.562125)

A 1,2-diacyl-sn-glycero-3-phosphoethanolamine zwitterion in which the acyl groups at C-1 and C-2 contain 37 carbons in total with 2 double bonds.

phosphatidylethanolamine 37:2

C42H80NO8P (757.562125)

A phosphatidylethanolamine in which the two acyl groups contain a total of 37 carbons and 2 double bonds.

1-palmitoyl-2-octadecadienoyl-sn-glycero-3-phosphocholine

C42H80NO8P (757.562125)

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the 1-acyl group is specified as palmitoyl while the acyl group (R) at position 2 is octadecadienoyl with the two double bonds at unspecified positions.

phosphatidylcholine 34:2

C42H80NO8P (757.562125)

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 34 carbons in total with 2 double bonds.

phosphatidylcholine (16:1/18:1)

C42H80NO8P (757.562125)

A phosphatidylcholine 34:2 in which the fatty acyl groups at positions 1 and 2 are specified as C16:1 and C18:1 respectively.

1,2-dioleoyl-sn-glycero-3-phospho-N-methylethanolamine

C42H80NO8P (757.562125)

A 1,2-diacyl-sn-glycero-3-phospho-N-methylethanolamine in which the phosphatidyl acyl groups are both specified as oleoyl (9Z-octadecenoyl); major species at pH 7.3.

PC(20:1(11Z)/14:1(9Z))

C42H80NO8P (757.562125)

PC(14:0/20:2(11Z,14Z))

C42H80NO8P (757.562125)

MePC(33:2)

C42H80NO8P (757.562125)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

dMePE(35:2)

C42H80NO8P (757.562125)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

Hex1Cer(40:6)

C46H79NO7 (757.5856223999999)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

PC(16:0-18:2)

C42H80NO8P (757.562125)

PANOMIX internal lipid standards

DGCC 32:1;O2

C42H79NO10 (757.5703674)

DGCC 35:6

C45H75NO8 (757.5492390000001)

DGTS 35:6;O

C45H75NO8 (757.5492390000001)

DGTS 36:5

C46H79NO7 (757.5856223999999)

PC O-16:0/18:3;O

C42H80NO8P (757.562125)

PC O-34:3;O

C42H80NO8P (757.562125)

PC P-16:0/18:2;O

C42H80NO8P (757.562125)

PC P-16:1/18:1;O

C42H80NO8P (757.562125)

PC 12:0_22:2

C42H80NO8P (757.562125)

PC 14:0_20:2

C42H80NO8P (757.562125)

PC 14:0/20:2

C42H80NO8P (757.562125)

PC 14:1_20:1

C42H80NO8P (757.562125)

PC 16:0_18:2

C42H80NO8P (757.562125)

PC 16:0/18:2

C42H80NO8P (757.562125)

PC 16:1_18:1

C42H80NO8P (757.562125)

PC 16:1/18:1

C42H80NO8P (757.562125)

PC 17:0_17:2

C42H80NO8P (757.562125)

PC 17:1/17:1

C42H80NO8P (757.562125)

PC 18:1/16:1

C42H80NO8P (757.562125)

PC 18:2/16:0

C42H80NO8P (757.562125)

LNAPE 37:2

C42H80NO8P (757.562125)

PE 11:0_26:2

C42H80NO8P (757.562125)

PE 15:0_22:2

C42H80NO8P (757.562125)

PE 15:0/22:2

C42H80NO8P (757.562125)

PE 15:1_22:1

C42H80NO8P (757.562125)

PE 16:1_21:1

C42H80NO8P (757.562125)

PE 17:0_20:2

C42H80NO8P (757.562125)

PE 17:1_20:1

C42H80NO8P (757.562125)

PE 17:2_20:0

C42H80NO8P (757.562125)

PE 18:1_19:1

C42H80NO8P (757.562125)

PE 18:2_19:0

C42H80NO8P (757.562125)

PE-NMe 18:0_18:2

C42H80NO8P (757.562125)

GalCer 17:1;O2/22:6

C45H75NO8 (757.5492390000001)

GalCer 17:2;O2/22:5

C45H75NO8 (757.5492390000001)

GalCer 19:2;O2/20:5

C45H75NO8 (757.5492390000001)

GalCer 39:7;O2

C45H75NO8 (757.5492390000001)

GlcCer 17:1;O2/22:6

C45H75NO8 (757.5492390000001)

GlcCer 17:2;O2/22:5

C45H75NO8 (757.5492390000001)

GlcCer 19:2;O2/20:5

C45H75NO8 (757.5492390000001)

GlcCer 39:7;O2

C45H75NO8 (757.5492390000001)

HexCer 17:1;O2/22:6

C45H75NO8 (757.5492390000001)

HexCer 17:2;O2/22:5

C45H75NO8 (757.5492390000001)

HexCer 19:2;O2/20:5

C45H75NO8 (757.5492390000001)

HexCer 36:2;O4

C42H79NO10 (757.5703674)

HexCer 39:7;O2

C45H75NO8 (757.5492390000001)

HexCer 9:0;O2/30:7

C45H75NO8 (757.5492390000001)

GLCAE 23:6

C49H75NO5 (757.564494)